A carregar...
TB vaccine development: where are we and why is it so difficult?
The development of an effective TB vaccine remains paramount to achieving the goal of global eradication of TB by 2050. The only licensed vaccine, BCG, has variable efficacy and is poorly effective in high burden countries. The development of promising candidate vaccines to either ‘boost’ a BCG prim...
Na minha lista:
| Publicado no: | Thorax |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4345977/ https://ncbi.nlm.nih.gov/pubmed/25432943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2014-205202 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|